Clinical Trials Logo

Rectal Neoplasms clinical trials

View clinical trials related to Rectal Neoplasms.

Filter by:

NCT ID: NCT04920435 Completed - Rectal Cancer Clinical Trials

Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging

RECTOMICS
Start date: January 2, 2019
Phase:
Study type: Observational

In patient with complete pathological response, surgery could be omitted without compromising progression-free or overall survival. A powerful prediction model is needed to guide management of this population. Radiomics features provide complementary information about tumor heterogenity. The aim of the investigators is to develop a model combining clinical and radiomic criteria able to predict complete pathological response.

NCT ID: NCT04896879 Completed - Rectal Cancer Clinical Trials

Experiences and Needs of Patients, Their Informal Caregiver and Healthcare Professionals Regarding LARS

Start date: November 22, 2016
Phase:
Study type: Observational

Exploration of the experiences and needs of patients with the low anterior resection syndrome, their informal caregiver and health care professionals. This is a qualitative study where semi-structured interviews will be conducted with patients and informal caregivers. next to that focus groups will be performed with healthcare professionals from different professions.

NCT ID: NCT04880772 Completed - Liver Metastases Clinical Trials

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

SPECS
Start date: July 15, 2021
Phase: N/A
Study type: Interventional

To determine whether exercise and nutrition prehabilitation improves patient outcomes after cancer surgery

NCT ID: NCT04855448 Completed - Rectal Cancer Clinical Trials

Evaluation of the Learning Curve in Low Anterior Resection for Rectal Resection With the Two Surgical Robots

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. This new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University. The Micro Hand S robot is safe and feasible in the preliminary study. However, the learning curve in low anterior resection for rectal resection with the Micro Hand S robot are unclear and whether the two surgical robots (Micro Hand S and da Vinci) shared a similar learning curve and the two robot can be trained simultaneously. Therefore, the investigators conduct this retrospective study to focus on this concern.

NCT ID: NCT04836741 Completed - Rectal Cancer Clinical Trials

Chinese Surgical Robot Clinical Study on Rectectomy for Rectal Cancer

Start date: July 1, 2015
Phase: N/A
Study type: Interventional

Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. This new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University. The Micro Hand S robot is safe and feasible in the preliminary study. However, compared with minimally invasive approaches (da Vici, laparoscope), the merits and demrits of rectectomy for rectal cancer are unclear. Therefore, the investigators conduct this retrospective study to focus on this concern.

NCT ID: NCT04795180 Completed - Rectal Cancer Clinical Trials

Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO)

BUTYCLO
Start date: December 10, 2013
Phase: Phase 2
Study type: Interventional

Low Anterior resection with total mesorectal excision and diversion loop ileostomy is a gold standard surgical treatment in rectal cancer. Ileostomy reversal performed in a second stage carries a high burden of postoperative complications. Terminal ileum and colon dysfunction during bowel disconnection could negatively influence postoperative morbimortality after loop ileostomy reversal in Rectal Cancer patients. Colonic microflora performs anaerobic breakdown of dietary fibre that reaches the gut in regular patients without ileostomy. One of the short-chain fatty acids (SCFAs) produced by bacteria is butyrate, the preferred substrate to be oxidized by colonocytes. The effects of butyrate irrigations before ileostomy closure on colonic mucosa will be studied in 45 rectal cancer patients. The effects of butyrate irrigation trough the efferent limb of loop ileostomy before its closure will be compared to the saline and non-irrigations group. Short term outcomes, colonic microbiota composition and functional outcomes will be evaluated after ileostomy reversal.

NCT ID: NCT04788368 Completed - Rectal Neoplasms Clinical Trials

TRECA - TREatment of Colorectal Adenomas and Early Colorectal CAncer in Region Västra Götaland

TRECA
Start date: March 1, 2021
Phase:
Study type: Observational [Patient Registry]

All early colorectal cancers (T1-T2) treated in the Region Västra Götaland from 2007-2020 will be evaluated. To establish the extent to which early colorectal cancers have been treated with local excision? How have treatment strategies changed over time? The study will provide information on where these patients have been treated in the Region Västra Götaland. During the study period, ESD was introduced as a treatment modality, and it will investigated how this may have influenced treatment strategies for complex adenomas. Clinical outcome measures will include recurrence rates and re-intervention rates for the respective treatments. Possible areas of improvement will be identified and determine if evidence based and best practice guidelines are met with the current treatment strategies in Region Västra Götaland.

NCT ID: NCT04787523 Completed - Rectal Neoplasms Clinical Trials

Rectrospect - a Retrospective Study of Treatment Response

Rectrospect
Start date: October 1, 2020
Phase:
Study type: Observational

Biopisies from patients diagnosed with rectal cancer between 2007-2019 will be cut into 4-6 micrometer thin sections for morphology and immunostaining. Every section will be numbered with a code that is connected to the patients personal identification number and the code list will be kept separately from the biopsies in a password protected file on the Sahlgrenska University Hospital server. Patient data and outcome regarding response to treatment will be collected from patient charts and the Swedish ColoRectal Cancer Registry, but all data will be numbered with the same code number and all results will be kept away from the code list. In order to achieve the stated aims, that is, to study how the molecular and cellular characteristics of the tumour and its surrounding microenvironment as well as the interaction of tumour cells and immune cells affect treatment response, several molecular and cellular techniques and assays may be applied.

NCT ID: NCT04779125 Completed - Rectal Cancer Clinical Trials

APEMESH II - Perineal Reconstruction

Start date: March 19, 2021
Phase: N/A
Study type: Interventional

The objective of this pilot study is to assess the safety, functional outcome, feasibility and the potential benefits of synthetic mesh strip and gluteus flap reconstruction in perineum in case-control setting.

NCT ID: NCT04761536 Completed - Rectal Cancer Clinical Trials

Volume-outcome Relationship in Rectal Cancer Surgery

Start date: January 2006
Phase:
Study type: Observational

Hospital centralization effect is reported to lower complications and mortality especially for high risk and complex general surgery operations, including colorectal surgery. However, no linear relation between volume and outcome has been demonstrated. Aim of the study was to evaluate the increased surgical volume effect on early outcomes of patient undergoing restorative anterior rectal resection (ARR).